DLA Piper has advised the shareholders of Symphar sp. z o.o. on the deal. Symphar sp. z o.o., a leading Polish pharmaceutical business, announced the sale...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here